Perspectives of industry on the development of stereoisomeric drugs

被引：0

作者：

Cayen, MN ^{[1
]}

机构：

[1] Schering Plough Corp, Res Inst, Drug Metab & Pharmacokinet, Kenilworth, NJ 07033 USA

来源：

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

SA14

引用

页码：R761 / R761

页数：1

共 50 条

[1] FDA POLICY STATEMENT FOR THE DEVELOPMENT OF NEW STEREOISOMERIC DRUGS
不详
[J]. CHIRALITY, 1992, 4 (05) : 338 - 340
[2] STEREOISOMERIC DRUGS - FDAS POLICY STATEMENT AND THE IMPACT ON DRUG DEVELOPMENT
TOMASZEWSKI, J
RUMORE, MM
[J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1994, 20 (02) : 119 - 139
[3] IDENTIFICATION SYSTEM FOR STEREOISOMERIC DRUGS
VANDERGOOT, H
TIMMERMAN, H
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1989, 10 (12) : 486 - 487
[4] PERSPECTIVES ON ANALYTICAL RESEARCH AND DEVELOPMENT WITHIN THE PHARMACEUTICAL-INDUSTRY - FOCUS ON PROTEINACEOUS DRUGS
STERNSON, LA
[J]. TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 1989, 8 (02) : 43 - 45
[5] PERSPECTIVES ON COLLABORATION AND INFRASTRUCTURE DEVELOPMENT - INDUSTRY PERSPECTIVES
KNAAK, JB
[J]. TOXICOLOGY LETTERS, 1995, 79 (1-3) : 305 - 312
[6] Industry Perspectives on the Development of Biologics
Kramer, Brian C.
[J]. PM&R, 2011, 3 (06) : S132 - S135
[7] PERSPECTIVES OF DEVELOPMENT IN NUCLEAR INDUSTRY
BARTHELT, K
[J]. ATOMWIRTSCHAFT-ATOMTECHNIK, 1987, 32 (8-9): : 398 - 402
[8] PERSPECTIVES OF THE TOOL INDUSTRY DEVELOPMENT
POLITOWSKI, M
[J]. MECHANIK MIESIECZNIK NAUKOWO-TECHNICZNY, 1980, 53 (12): : 647 - 652
[9] Industry Perspectives on Market Access of Innovative Drugs: The Relevance for Oncology Drugs
Pauwels, Kim
Huys, Isabelle
Casteels, Minne
Simoens, Steven
[J]. FRONTIERS IN PHARMACOLOGY, 2016, 7
[10] ANTIALLERGIC DRUGS - STATUS AND PERSPECTIVES OF DEVELOPMENT
GUSHCHIN, IS
SARAF, AS
[J]. KHIMIKO-FARMATSEVTICHESKII ZHURNAL, 1992, 26 (04): : 4 - 20

← 1 2 3 4 5 →